![Novartis Patient Support](https://usim.beprod.us.pluvicto.com/sites/us_pluvicto_com/files/styles/hero_full_width_width_2560/public/2024-07/novartis-patient-support-1_0.png?itok=rvQcO25p)
Ongoing support to help start and stay on PLUVICTO treatment
Once you and your health care provider decide to begin PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan), Novartis Patient Support is here to help.
Once you and your health care provider decide to begin PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan), Novartis Patient Support is here to help.
What is the most important information I should know about PLUVICTO?
Use of PLUVICTO involves exposure to radioactivity. Long-term, accruing radiation exposure is associated with an increased risk for cancer...
What is PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan)?
PLUVICTO is a radiopharmaceutical used to treat adults with an advanced cancer called prostate-specific membrane antigen–positive metastatic castration-resistant prostate cancer (PSMA-positive mCRPC) that...